Patient experience

Psychedelic Healing

Could magic mushrooms help reboot the brain? Article from BBC Focus Magazine focusing on the experience of Kirk Rutter, a participant in the Imperial College psilocybin therapy study

Can Magic Mushrooms Provide Lasting Peace?

Psilocybin has been illegal in the United States for more than 40 years. But Mr. Mihai, who had just finished treatment for Stage 3 Hodgkin’s lymphoma, was participating in a study looking at whether the drug can reduce anxiety and depression in cancer patients.

Just One Dose of This Psychedelic Drug Can Ease Anxiety

In two new studies released simultaneously by researchers at New York University and Johns Hopkins, doctors reveal that a single dose of psilocybin—a compound from magic mushrooms—can ease anxiety and depression for up to six months.

Roland Griffiths Talks About Psilocybin Research

Insights from Professor Roland Griffiths into the psilocybin research carried out at Johns Hopkins University looking at anxiety, depression and psychological distress in cancer patients.

Real Trip Treatment

Research into psychedelics, shut down for decades, is now yielding exciting results. In this article from The New Yorker, Michael Pollan presents a considered overview of psychedelic-assisted therapy, its history and its potential benefit to patients.

‘Magic Mushrooms’ and The Healing Trip

The way in which we commonly perceive so-called magic mushrooms—as the means to youthful psychedelic adventure—is undergoing a radical transformation.

Can Mushrooms Treat Depression?

"The brains on psilocybin showed radically different connectivity patterns between cortical regions (the parts thought to play an important role in consciousness). "

Hallucinogens Have Doctors Tuning In Again

Scientists are taking a new look at hallucinogens, which became taboo among regulators after enthusiasts like Timothy Leary promoted them in the 1960s with the slogan “Turn on, tune in, drop out.”